Singapore: +65-85097465 | India: +91-40-42023318
  U.S / Canada Toll Free: +1-866-259-4781
  Zimbabwe: +263-735539685, 773876488

          

Clinical Trial News

Palbociclib expanded access program now open to eligible U.S. patients with HR+, HER2- advanced breast cancer

Pfizer Inc. has announced that the company has initiated a multi-center, open-label expanded access program (EAP) in the United States for the investigational CDK 4/6 inhibitor, palbociclib.

Clinical trials of unscientific, 'alternative' medicines denounced by experts

Experts writing in the Cell Press journal Trends in Molecular Medicine call for an end to clinical trials of "highly implausible treatments" such as homeopathy and reiki.

Commercialization delayed by early bottlenecks in developing biopharmaceutical products

An analysis of patented university inventions licensed to biotechnology firms has revealed early bottlenecks on the path to commercialization.

NSAIDs may halve breast cancer recurrence in overweight women

In a new study, overweight and obese breast cancer patients exhibited a 52% lower rate of recurrence and a 28-month delay in recurrence if they were regularly taking NSAIDs.

Gastric cancer: could Botox be an alternative to chemo?

Research into the role of the vagal nerve in stomach cancer has led to novel methods for severing the nerve-tumor connection. One of these, surprisingly, is Botox injections.

Alzheimer's disease: are we close to finding a cure?

There seems to be more focus than ever on Alzheimer's research. But how close are scientists to developing effective prevention and treatment strategies for the disease?

What is a case-control study in medical research?

Find out how 'cases' are compared with 'controls' in this type of medical research study, which is a relatively quick and easy way to find clues, but with scientific limitations.

Baldness cured with bone marrow disease drug in alopecia areata patients

A drug called ruxolitinib restored hair in patients with alopecia areata - an autoimmune disease that causes hair loss - according to the early results of a clinical trial.



James Lind Institute Newsletter
James Lind Institute Linkedin
James Lind Institute RSS
James Lind Institute Email Update
James Lind Institute Blog
James Lind Institute Facebook